NHAS
CNST

Novo Holdings A/S’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Novo Holdings A/S’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-699,415
Closed -$16.4M – 59
2021
Q1 		$16.4M Buy
699,415
+100,464
+17% +$3.04M 0.68% 26
2020
Q4 		$17.3M Buy
598,951
+20,817
+4% +$524K 0.74% 26
2020
Q3 		$11.7M Buy
578,134
+141,003
+32% +$3.44M 0.58% 25
2020
Q2 		$13.1M Buy
437,131
+268,750
+160% +$9.68M 0.85% 19
2020
Q1 		$5.29M Buy
+168,381
New +$5.85M 0.35% 22

Other funds holding CNST

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PIM
Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Novo Holdings A/S's CNST Position: Q2 2021 in Review

Novo Holdings A/S sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2021, closing a stake of 699,415 shares — an estimated $16.4M sold.

Novo Holdings A/S first reported a position in CNST in Q1 2020 and held it in 5 quarters. The position peaked at $17.3M in Q4 2020. 153 funds tracked by Wall St. Rank hold CNST as of Q2 2021.

  • Novo Holdings A/S reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Novo Holdings A/S sold 699,415 Constellation Pharmaceuticals, Inc. shares in Q2 2021, an estimated $16.4M.
  • Novo Holdings A/S first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2020 and held it in 5 quarters.
  • Novo Holdings A/S's Constellation Pharmaceuticals, Inc. position peaked at $17.3M in Q4 2020.
  • 153 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2021.

Based on Novo Holdings A/S's 13F filing for Q2 2021, filed 16 Aug 2021.